Media Release May 07, 2026
Siegfried included in Dow Jones Best-in-Class Europe Index
Read more Media Release Apr 29, 2026
Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing
Read more Media Release Apr 24, 2026
Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia
Read more Media Release Apr 16, 2026
Siegfried shareholders approve all proposals at Annual General Meeting 2026
Read more Media Release Feb 20, 2026
Siegfried delivers strong profitability and continued growth
Read more Media Release Feb 05, 2026
Changes to Siegfried’s Board of Directors
Read more
